Amgen Inc (NAS:AMGN)
$ 305.84 -0.66 (-0.22%) Market Cap: 164.06 Bil Enterprise Value: 218.38 Bil PE Ratio: 43.69 PB Ratio: 32.64 GF Score: 91/100

Q3 2020 Amgen Inc Earnings Call Transcript

Oct 28, 2020 / 09:00PM GMT
Release Date Price: $216.38 (-3.17%)
Operator

My name is April, and I will be your conference facilitator today for Amgen's Third Quarter 2020 Financial Results Conference Call. (Operator Instructions)

I would now like to introduce Arvind Sood, Vice President of Investor Relations. Mr. Sood, you may now begin.

Arvind Sood;Robert A.
Amgen Inc. - VP of IR

Okay. Thank you, April. Good afternoon, everybody. I, together with several members of our leadership team that you will hear from today, would like to welcome you to our Q3 call. The format of our Q2 call was very well received. So we'll stick to keeping our prepared comments to a minimum and limit the overall duration of the call to 1 hour. The slides have been posted.

Just a quick reminder that we use non-GAAP financial measures in our presentation, and some of the statements will be forward-looking statements. Our 10-K and subsequent filings identify factors that could cause our actual results to differ materially.

So with that, I would like to turn the call over to our Chairman and CEO, Bob Bradway. Bob?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot